Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group (2007)
Klimm, B,
Eich, HT,
Haverkamp, H,
Lohri, A,
Koch, P,
Boissevain, F,
...
Background: The optimal treatment of elderly patients with Hodgkin's lymphoma (HL) is still a matter of debate. Since many of these patients receive combined modality treatment, we evaluated the...
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group (2006)
Klimm, B.,
Eich, H. T.,
Haverkamp, H.,
Lohri, A.,
Koch, P.,
Boissevain, F.,
...
Background: The optimal treatment of elderly patients with Hodgkin's lymphoma (HL) is still a matter of debate. Since many of these patients receive combined modality treatment, we evaluated the...
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group (2006)
Klimm, B.,
Eich, H. T.,
Haverkamp, H.,
Lohri, A.,
Koch, P.,
Boissevain, F.,
...
Background: The optimal treatment of elderly patients with Hodgkin's lymphoma (HL) is still a matter of debate. Since many of these patients receive combined modality treatment, we evaluated the...
Revised response criteria for malignant lymphomas. From the members of the International Harmonization Project (IHP) of the competence network malignant lymphoma (2005)
Cheson, BD,
Pfistner, B,
Juweid, ME,
Specht, L,
Rosen, ST,
Gascoyne, R,
...
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly) (2005)
Ballova, V.,
Haverkamp, H.,
Pfistner, B.,
Müller-Hermelink, H. K.,
Dühmke, E.,
...
In contrast to younger patients, the prognosis of elderly patients with advanced Hodgkin's disease (HD) has not improved substantially over the last 20 years. We thus carried out a prospectively...
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial (2004)
Sieber, M.,
Tesch, H.,
Pfistner, B.,
Rueffer, U.,
Paulus, U.,
Munker, R.,
...
Background: The purpose of this study was to compare the efficacy of the hybrid chemotherapeutic regimen COPP/ABV/IMEP...
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial (2002)
Schmitz, N.,
Pfistner, B.,
Sextro, M.,
Sieber, M.,
Carella, A.M.,
Haenel, M.,
...
Background: High-dose chemotherapy followed by transplantation of autologous haemopoietic stem cells (BEAMHSCT) is frequently used to treat patients with relapsed Hodgkin's disease. We aimed to...
Cerebellar abiotrophy in pure-bred Arabians. (1995)
GERBER, H,
GAILLARD, C,
FATZER, R,
MARTI, E,
PFISTNER, B,
Sustronck, Bart,
...
Cerebelläre Abiotrophie bei Vollblutaraber-Fohlen (1995)
GERBER, H,
GAILLARD, CL,
FATZER, R,
MARTI, E,
PFISTNER, B,
Sustronck, Bart,
...